Xencor Names Bart Cornelissen as SVP and Chief Financial Officer
Xencor Inc., a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, has appointed Bart Cornelissen [alumnus RSM MScBA] as senior vice president and chief…
Outlet:
Contract Pharma
Media Type:
Online
Tuesday, 9 April 2024